Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05060016 |
| Title | A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC) |
| Acronym | DeLLphi-301 |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Amgen |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | POL | NLD | ITA | GRC | GBR | FRA | ESP | DNK | DEU | CHE | BEL | AUT |